⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3311686 | 0.78 | — | — | |
| SCHEMBL27724939 | 0.75 | HSPB1 (0.53) | — | |
| SCHEMBL545380 | 0.69 | — | — | |
| Ammonia Solution, Strong SCHEMBL27496972 | 0.67 | MAPT (0.63) | — | |
| Hydrochloric Acid SCHEMBL27929116 | 0.67 | MAPT (0.63) | — | |
| SCHEMBL19859330 | 0.65 | MAPT (0.61) | — | |
| SCHEMBL297591 | 0.65 | — | — | |
| SCHEMBL449171 | 0.65 | — | — | |
| SCHEMBL9486037 | 0.65 | CYP19A1 (0.39) | — | |
| Pyrazine SCHEMBL27515795 | 0.64 | MAPT (0.65) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 304 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240197898-A1 | SUBSTITUTED BENZO[5,6][1,4]DIAZEPINO[1,2-a]INDOLES FOR THE TREATMENT OF PROLIFERATIVE DISORDERS | IMMUNOGEN, INC. | 2024-06-20 | — | — | US | claimed |
| CN-116606279-A | Fluoroquinolone compound and preparation method and application thereof | 广东工业大学 | 2023-08-18 | — | — | CN | claimed |
| CN-116514903-A | Cytotoxic benzodiazepine derivatives | 伊缪诺金公司 | 2023-08-01 | — | — | CN | claimed |
| US-20230233697-A1 | CYTOTOXIC BENZODIAZEPINE DERIVATIVES | IMMUNOGEN, INC. | 2023-07-27 | — | — | US | claimed |
| US-20230094471-A1 | CYTOTOXIC BIS-BENZODIAZEPINE DERIVATIVES AND CONJUGATES THEREOF WITH CELL-BINDING AGENTS FOR INHIBITING ABNORMAL CELL GROWTH OR FOR TREATING PROLIFERATIVE DISEASES | IMMUNOGEN, INC. (US) | 2023-03-30 | — | — | US | claimed |
| CN-111909082-B | Pyridine hydrazone derivatives, and preparation method and application thereof | 湖南大学 | 2022-09-13 | — | — | CN | claimed |
| EP-3947395-A1 | CYTOTOXIC BIS-BENZODIAZEPINE DERIVATIVES AND CONJUGATES THEREOF WITH CELL-BINDING AGENTS FOR INHIBITING ABNORMAL CELL GROWTH OR FOR TREATING PROLIFERATIVE DISEASES | ImmunoGen, Inc. (US) | 2022-02-09 | — | — | EP | claimed |
| CN-113661172-A | Cytotoxic bis-benzodiazepine derivatives and conjugates thereof with cell-binding agents for use in inhibiting abnormal cell growth or treating proliferative diseases | 伊缪诺金公司 | 2021-11-16 | — | — | CN | claimed |
| CN-113121517-A | Triazole derivative and preparation method and application thereof | 中山大学 | 2021-07-16 | — | — | CN | claimed |
| US-20200397914-A1 | BENZODIAZEPINE DERIVATIVES | IMMUNOGEN, INC. | 2020-12-24 | — | — | US | claimed |
| EP-1438053-A1 | PYRIMIDINE DERIVATIVES, PHARMACEUTICAL AGENT CONTAINING SAID COMPOUNDS, USE AND METHOD FOR MAKING SAME | Boehringer Ingelheim Pharma GmbH & Co.KG (DE) | 2004-07-21 | — | — | EP | claimed |
| WO-2003032997-A1 | PYRIMIDINE DERIVATIVES, PHARMACEUTICAL AGENT CONTAINING SAID COMPOUNDS, USE AND METHOD FOR MAKING SAME | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2003-04-24 | — | — | WO | claimed |
| US-5403932-A | Phosphoramidates useful as antitumor agents | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1995-04-04 | — | — | US | claimed |
| EP-0233051-B1 | ANTIARRHYTHMIC AGENTS | Pfizer Limited (GB) | 1993-09-15 | — | — | EP | claimed |
| EP-0418292-A4 | PHOSPHORAMIDES USEFUL AS ANTITUMOR AGENTS | — | 1991-09-25 | — | — | EP | claimed |
| EP-0418292-A1 | PHOSPHORAMIDES USEFUL AS ANTITUMOR AGENTS | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1991-03-27 | — | — | EP | claimed |
| WO-1989011484-A1 | PHOSPHORAMIDES USEFUL AS ANTITUMOR AGENTS | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1989-11-30 | — | — | WO | claimed |
| EP-0324543-A2 | Antiarrhythmic agents | Pfizer Limited (GB) | 1989-07-19 | — | — | EP | claimed |
| US-4806536-A | Piperazinyl-substituted pyridine and imidazole anti-arrhythmic agents | PFIZER, INC. (US) | 1989-02-21 | — | — | US | claimed |
| EP-0233051-A2 | Antiarrhythmic Agents | Pfizer Limited (GB) | 1987-08-19 | — | — | EP | claimed |